A ten-week double-blinded randomised control trial to evaluate the effectiveness and tolerability of the Flow tDCS device with an additional ten-week follow-up.
Flow tDCS can effectively and efficiently be delivered through a primary healthcare general practice service and patients will choose to use. The widespread availability of tDCS in primary care general practice should be considered.
Baukaite, E., Noel-Johnson, A., Walker, K., Griffiths, C.
Jun, 2024
Experiences and Value of Flow; Used at Home for Specialist Perinatal Mental Health Service and Maternal Loss Psychology Service Patients with Depression